Meet Laura, a real Verzenio patient.
Verzenio + hormone therapy is approved to treat adults diagnosed with HR+, HER2–, node positive, early breast cancer with a high chance of returning, as determined by your doctor.
Laura is a lot of things: a wife, a mom, a full-time employee, a daughter, and a friend. She's also a breast cancer survivor.
In 2021, Laura discovered a lump in her breast. When doctors determined it was early breast cancer, her life turned upside down.
After active treatment, her doctor suggested a therapy to help prevent her breast cancer from coming back. Laura wanted to do everything she could to prevent recurrence, so she started Verzenio, along with hormone therapy.
Watch Laura's story below.
"My first thought was, I will do Verzenio if it increases the odds that my kids won't have to hear me say that it's come back."
SELECT SAFETY INFORMATION
Verzenio may cause serious side effects, including:
Diarrhea is common with Verzenio, may sometimes be severe and may cause dehydration or infection. The most common time to develop diarrhea is during the first month of Verzenio treatment. If you develop diarrhea during treatment with Verzenio, your healthcare provider may tell you to temporarily stop taking it, stop your treatment, or decrease your dose. If you have any loose stools, start taking an antidiarrheal medicine (such as loperamide), drink more fluids, and tell your healthcare provider right away.
Learn more about how Verzenio + hormone therapy can be used to treat HR+, HER2–, node-positive early breast cancer.
Have a Verzenio story of your own?
Share your Verzenio story. Call 1-800-LillyRx (1-800-545-5979)
Learn about Savings & Support, including how to enroll in the Verzenio Continuous Care Program